Bridger Management, LLC Insulet Corp Transaction History

Bridger Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$154.67 - $290.89 $1.83 Million - $3.43 Million	11,800 New	11,800 $1.88 Million
Q2 2022 Aug 15, 2022	BUY	$186.4 - $279.02 $7.64 Million - $11.4 Million	41,000 New	41,000 $8.94 Million
Q3 2021 Nov 15, 2021	SELL	$260.36 - $307.27 $26.1 Million - $30.8 Million	-100,145 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$225.52 - $304.06 $1.09 Million - $1.47 Million	4,850 Added 5.09%	100,145 $27.5 Million
Q1 2021 May 14, 2021	BUY	$235.95 - $293.05 $22.5 Million - $27.9 Million	95,295 New	95,295 $24.9 Million

687

62.6M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.5B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Bridger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridger Management, LLC with notifications on news.